Cargando…
The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas
Immune checkpoint blockade, an immunotherapy, has been applied in multiple systemic malignancies and has improved overall survival to a relatively great extent; whether it can be applied in breast cancer remains unknown. We endeavored to explore possible factors that may influence immunotherapy outc...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452722/ https://www.ncbi.nlm.nih.gov/pubmed/34545132 http://dx.doi.org/10.1038/s41598-021-98131-4 |